Methotrexate Drugs Market Analysis

  • Report ID: 2738
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Global Methotrexate Drug Market TOC

 

  1. Market Definition
    1. Definition
    2. Market Segmentation
    3. Product Overview
  2. Assumptions and Acronyms
  3. Research Methodology
    1. Research Process
    2. Primary Research
      1. Manufacturers
      2. Suppliers/Distributors
      3. End-Users
    3. Secondary Research
    4. Market Size Estimation
  4. Analyst Review
  5. Executive Summary – Global Methotrexate Drug Market
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Market Trends
    4. Opportunities
  7. Regulatory and Standards Landscape
    1. FDA
    2. WHO
    3. Others
  8. Industry Risk Analysis
  9. World Economic Outlook: Challenges for Global Recovery and its Impact on Global Methotrexate Drug Market
  10. Impact of COVID-19 on the Global Methotrexate Drug Market
  11. Epidemiology Analysis of Cancer and Rheumatoid Arthritis
  12. End-user analysis
  13. Industry Supply Chain Analysis
  14. Competitive Landscape
    1. Company Market Share Analysis
    2. Company Profiles
      1. Pfizer Inc.
      2. Azurity Pharmaceuticals, Inc.
      3. Cumberland Pharmaceuticals Inc.
      4. Teva Pharmaceuticals USA, Inc.
      5. Amneal Pharmaceuticals LLC
      6. Sun Pharmaceutical Industries Ltd.
      7. Aurobindo Pharma Limited,
      8. Sandoz Inc
      9. Hikma Pharmaceuticals PLC
      10. Eisai Co., Ltd.
      11. Other prominent players
  15. Global Methotrexate Drug Market 2023-2036
    1. Market Overview
    2. By Value (USD Million)
      1. By Type  
        1. >10 mg, 2023-2036F (USD Million)
        2. >15 mg/ml, 2023-2036F (USD Million)
        3. 17.5 mg/ml – 25 mg/ml, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      2. By Disease Type
        1. Cancer, 2023-2036F (USD Million)
          1. Breast Cancer, 2023-2036F (USD Million)
          2. Leukemia, 2023-2036F (USD Million)
          3. Lung Cancer, 2023-2036F (USD Million)
          4. Lymphoma, 2023-2036F (USD Million)
          5. Gestational Trophoblastic Disease, 2023-2036F (USD Million)
          6. Osteosarcoma, 2023-2036F (USD Million)
        2. Autoimmune Diseases, 2023-2036F (USD Million)
          1. Psoriasis, 2023-2036F (USD Million)
          2. Rheumatoid Arthritis, 2023-2036F (USD Million)
          3. Crohn's Disease, 2023-2036F (USD Million)
          4. Others, 2023-2036F (USD Million)
        3. Ectopic Pregnancy, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      3. By Drug Type
        1. Branded, 2023-2036F (USD Million)
        2. Generics, 2023-2036F (USD Million)
      4. By Route Of Administration
        1. Injectable, 2023-2036F (USD Million)
        2. Oral, 2023-2036F (USD Million)
      5. By End User
        1. Hospitals, 2023-2036F (USD Million)
        2. Specialty Clinics, 2023-2036F (USD Million)
        3. Home Healthcare, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      6. By Region
        1. North America, 2023-2036F (USD Million)
        2. Europe, 2023-2036F (USD Million)
        3. Asia Pacific, 2023-2036F (USD Million))
        4. Latin America, 2023-2036F (USD Million)
        5. Middle East & Africa, 2023-2036F (USD Million)
  16. North America Methotrexate Drug Market 2023-2036
    1.  Market Overview
    2. By Value (USD Million)
      1. By Type 
        1. >10 mg, 2023-2036F (USD Million)
        2. >15 mg/ml, 2023-2036F (USD Million)
        3. 17.5 mg/ml – 25 mg/ml, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      2. By Disease Type
        1. Cancer, 2023-2036F (USD Million)
          1. Breast Cancer, 2023-2036F (USD Million)
          2. Leukemia, 2023-2036F (USD Million)
          3. Lung Cancer, 2023-2036F (USD Million)
          4. Lymphoma, 2023-2036F (USD Million)
          5. Gestational Trophoblastic Disease, 2023-2036F (USD Million)
          6. Osteosarcoma, 2023-2036F (USD Million)
        2. Autoimmune Diseases, 2023-2036F (USD Million)
          1. Psoriasis, 2023-2036F (USD Million)
          2. Rheumatoid Arthritis, 2023-2036F (USD Million)
          3. Crohn's Disease, 2023-2036F (USD Million)
          4. Others, 2023-2036F (USD Million)
        3. Ectopic Pregnancy, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      3. By Drug Type
        1. Branded, 2023-2036F (USD Million)
        2. Generics, 2023-2036F (USD Million)
      4. By Route Of Administration
        1. Injectable, 2023-2036F (USD Million)
        2. Oral, 2023-2036F (USD Million)
      5. By End User
        1. Hospitals, 2023-2036F (USD Million)
        2. Specialty Clinics, 2023-2036F (USD Million)
        3. Home Healthcare, 2023-2036F (USD Million)
        4. Others, 2023-2036F (USD Million)
      6. By Country
        1. United States, 2023-2036F (USD Million)
        2. Canada, 2023-2036F (USD Million)
  17. Europe Methotrexate Drug Market 2023-2036
    1. Market Overview
    2. By Value (USD Million)
      1. By Type  
      2. By Disease Type
      3. By Drug Type
      4. By Route Of Administration
      5. By End User
      6. By Country
        1. United Kingdom, 2023-2036F (USD Million)
        2. Germany, 2023-2036F (USD Million)
        3. France, 2023-2036F (USD Million)
        4. Italy, 2023-2036F (USD Million)
        5. Spain, 2023-2036F (USD Million)
        6. Russia, 2023-2036F (USD Million)
        7. Netherlands, 2023-2036F (USD Million)
        8. Rest of Europe, 2023-2036F (USD Million)
  18. Asia Pacific Methotrexate Drug Market 2023-2036
    1.  Market Overview
    2. By Value (USD Million)
      1. By Type  
      2. By Disease Type
      3. By Drug Type
      4. By Route Of Administration
      5. By End User
      6. By Country
        1. China, 2023-2036F (USD Million)
        2. India, 2023-2036F (USD Million)
        3. Japan, 2023-2036F (USD Million)
        4. South Korea, 2023-2036F (USD Million)
        5. Singapore, 2023-2036F (USD Million)
        6. Australia, 2023-2036F (USD Million)
        7. Rest of Asia Pacific, 2023-2036F (USD Million)
  19. Latin America Methotrexate Drug Market 2023-2036
    1. Market Overview
    2. By Value (USD Million)
      1. By Type 
      2. By Disease Type
      3. By Drug Type
      4. By Route Of Administration
      5. By End User
      6. By Country
        1. Brazil, 2023-2036F (USD Million)
        2. Mexico, 2023-2036F (USD Million)
        3. Argentina, 2023-2036F (USD Million)
        4. Rest of Latin America, 2023-2036F (USD Million)
  20. Middle East & Africa Methotrexate Drug Market 2023-2036
    1. Market Overview
    2. By Value (USD Million)
      1. By Type 
      2. By Disease Type
      3. By Drug Type
      4. By Route Of Administration
      5. By End User
      6. By Country
        1. Israel, 2023-2036F (USD Million)
        2. GCC, 2023-2036F (USD Million)
        3. South Africa, 2023-2036F (USD Million)
        4. Rest of Middle East & Africa, 2023-2036F (USD Million)

Methotrexate Drugs Market Analysis

Disease Type (Cancer, Autoimmune Diseases, Ectopic Pregnancy)

The cancer segment in the methotrexate drugs market is expected to grow at a CAGR of 3.2% during the forecast period. Methotrexate drugs slows down the growth of cancer cells. The growth of the segment is due to the rising incidence rates of various types of cancers across the globe. For instance, according to the National Cancer Institute, Prostate, lung, and colorectal cancers account for an estimated 43% of all cancers diagnosed in men in 2020. For women, the three most common cancers are colorectal, breast, and lung which accounted for an estimated 50% of all new cancer diagnoses in women in 2020. In addition, higher usage of methotrexate in cancer treatment than in arthritis or psoriasis is also a major factor catering to the segment’s growth in the market. It is the initial treatment administered to cancer patients and is also used in combination therapy. In Japan, methotrexate is administered as the first-line treatment for cancer.

End-User (Hospitals, Specialty Clinics, Home Healthcare)

Methotrexate drugs market from the hospital segment is expected to garner a significant share by 2037, due to the increasing influx of patients with target diseases. Methotrexate is a kind of chemotherapy, and it is a treatment for a variety of cancers. According to the National Library of Medicine, in the United States, an estimated 60,000 cancer patients with cancer are hospitalized each year for chemotherapy. As the number of patients seeking treatment at hospitals continues to rise, the segment is further expected to grow with the highest CAGR of 3.3% during the forecast period. Besides, specialty clinics are expected to grow at a significant growth rate.

Our in-depth analysis of the global methotrexate drugs market includes the following segments:

     Dosage Form

  • >10 mg
  • >15 mg./ml
  • 17.5 mg/ml – 25 mg/ml

     Drug Type

  • Branded
  • Generics

     Disease Type

  • Cancer
  • Autoimmune Diseases
  • Ectopic Pregnancy

     Route of Administration

  • Injectable
  • Oral

     End-User

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2738
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of methotrexate drugs is estimated at USD 597.64 million.

The methotrexate drugs market size was valued at USD 584.09 million in 2024 and is set to exceed USD 846.99 million by 2037, registering over 2.9% CAGR during the forecast period i.e., between 2025-2037. The surge in the prevalence of rheumatoid arthritis and the increasing prevalence of cancer will drive the market growth.

North America industry is set to hold largest revenue share of 41% by 2037, due to rising demand for methotrexate drugs in the region.

The major players in the market include Pfizer Inc., Azurity Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Sandoz Inc, Hikma Pharmaceuticals PLC, Eisai Co., Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample